Low-density lipoprotein particle number and risk for cardiovascular disease.
about
LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL ManagementImpact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients.Characterization of metabolic interrelationships and in silico phenotyping of lipoprotein particles using self-organizing mapsLipoproteins and lipoprotein metabolism in periodontal disease.HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study.Treatment of dyslipidemia in patients with type 2 diabetes.HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infectionPlasma level of adrenomedullin is influenced by a single nucleotide polymorphism in the adiponectin geneLDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients.Metabolic effects of adjunctive aripiprazole in clozapine-treated patients with schizophreniaHigh-fat meal effect on LDL, HDL, and VLDL particle size and number in the Genetics of Lipid-Lowering Drugs and Diet Network (GOLDN): an interventional study.High Intensity Interval- vs Moderate Intensity- Training for Improving Cardiometabolic Health in Overweight or Obese Males: A Randomized Controlled Trial.Diagnostic markers based on a computational model of lipoprotein metabolismEthnic differences in low-density lipoprotein particle size in hypertensive adults.Lipids for psychiatrists - an overview.Low-density lipoprotein size and cardiovascular risk assessment.Sex differences in HDL ApoC-III in American Indian youth.The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on AtherosclerosisLipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool.Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics.Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.Comparing effects of soybean oil- and palm olein-based mayonnaise consumption on the plasma lipid and lipoprotein profiles in human subjects: a double-blind randomized controlled trial with cross-over design.Effects of cardiovascular lifestyle change on lipoprotein subclass profiles defined by nuclear magnetic resonance spectroscopy.Effects of exercise on lipoprotein particles in women with polycystic ovary syndromeBiomarkers related to aging in human populations.Reduction in dietary trans fat intake is associated with decreased LDL particle number in a primary prevention population.The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk.Hepatitis C Virus-Associated Alterations in Lipid and Lipoprotein Levels: Helpful or Harmful to the Heart?Effect of combination of dietary fish protein and fish oil on lipid metabolism in rats.Malnutrition, inflammation, and lipids in a cohort of dialysis patients.A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trial.A case-control study on the relationship between HDL2b and non-alcoholic fatty liver disease in Chinese type 2 diabetic patients.Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis.Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age).PROCAM Study: risk prediction for myocardial infarction using microfluidic high-density lipoprotein (HDL) subfractionation is independent of HDL cholesterol.Once-daily abacavir/lamivudine and ritonavir-boosted atazanavir for the treatment of HIV-1 infection in antiretroviral-naïve patients: a 48-week pilot study.Acute exercise and training alter blood lipid and lipoprotein profiles differently in overweight and obese men and women.Additive Antiatherogenic Effects of CETP rs708272 on Serum LDL Subfraction Levels in Patients with CHD Under Statin Therapy.
P2860
Q21558651-07B6F824-58FF-49B3-B7C1-0B1B813F812BQ30234825-B2CA84EB-F201-4AEA-8BCD-2F7B13B4360FQ30423610-21DF4A47-2EFF-411A-AC53-281ECCAEF524Q33577893-D4783FBC-F9DC-4511-81C3-DEAB02BD2339Q34106350-65DF7C34-C192-4454-82F7-130AF778E750Q34355660-A979537A-0ED8-43A6-869D-CD0B5F81AE5FQ34499472-C76EF4EF-ED8A-49B4-9E2E-1E9682577246Q34712485-62C8EFE8-6C4D-4341-A7C8-20DB26D1E1C0Q34925433-763F6888-AA8C-49A0-A7FE-86446CDEE988Q35037695-C8A33C5E-48A7-4A55-90A2-59EA667A43AAQ35082389-A2AAEF0D-7D55-4351-A948-F1FF74D5BB59Q35509384-4BBD91C6-1311-4C27-80E0-40CB2A9B0A22Q35816301-C305F081-F267-40F0-A768-523DA18F9C4BQ35834874-CAD114C5-54D1-4232-A6F3-8C3FE2AC3219Q36252520-0367F474-4E22-4AFA-9BE1-13F23E19C5A9Q36310307-F934E69E-ABEE-4D81-AC75-922012354FDDQ36349994-F19C06A3-1A04-4D22-BC05-1436C1634953Q36478598-CFB42C9F-CC6D-4C5A-978D-CBDE0EFEC374Q36663488-2019C1CE-372D-4ABF-B025-0CA766A1322BQ36725904-D421F3E5-772C-454C-BDE8-CDF98C38F11EQ37004622-C386998F-1578-4AF4-9F48-090A6338CDB6Q37004712-53321075-2740-4F06-9234-D3D0416CB2E9Q37086312-1CA682A6-CB52-4D8E-9E91-617740A5EC99Q37185625-AA965358-6B4C-4167-A294-626C637CE9FCQ37268440-3CC354CB-CE96-4BF6-8CF0-17C6491C63D5Q37307972-3F70D43F-5E02-4A2E-B022-7B70E51BC386Q37323794-B4B9738B-71B7-4329-9935-A5BDE3E3FEA8Q37620075-D716D0F0-71E0-4DC7-B414-9DE7E97BC7A8Q37902963-11230F98-19B3-4EA3-917D-07FAE18A213CQ41974163-868592AA-55F3-42E9-950F-33BF1F883229Q42032402-1FBE4521-5F85-4065-8DF8-855BFA5A6C2BQ42171367-C1E7372C-557D-4421-A6F6-375FFE8B334CQ42787162-05CC62CD-D824-4DA0-ABF2-7DE7334536C0Q43281335-8CBE86A3-5AAB-470E-8510-76424999B945Q44913770-36911A5D-ACBC-4CA2-8262-C498E13520D9Q45046990-EF99694A-D5C2-4074-AD00-01B44ECCEF36Q46498318-4E84F59D-4417-4ABF-8AF6-EAB1DD3871B7Q46544844-E5CA86D7-EA7F-435E-89A0-592980254648Q48015507-818EC97E-5674-4700-ACEC-A4EF2FC7A460Q51296042-074C822F-CD3F-4780-A78B-6D908F36DFF0
P2860
Low-density lipoprotein particle number and risk for cardiovascular disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Low-density lipoprotein particle number and risk for cardiovascular disease.
@ast
Low-density lipoprotein particle number and risk for cardiovascular disease.
@en
type
label
Low-density lipoprotein particle number and risk for cardiovascular disease.
@ast
Low-density lipoprotein particle number and risk for cardiovascular disease.
@en
prefLabel
Low-density lipoprotein particle number and risk for cardiovascular disease.
@ast
Low-density lipoprotein particle number and risk for cardiovascular disease.
@en
P2860
P1476
Low-density lipoprotein particle number and risk for cardiovascular disease.
@en
P2093
James D Otvos
William C Cromwell
P2860
P2888
P304
P356
10.1007/S11883-004-0050-5
P577
2004-09-01T00:00:00Z